1. GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer
   Shimeng Cheng et al, 2017, PLOS ONE CrossRef
2. O-GlcNAcylation is associated with the development and progression of gastric carcinoma
   Tae Jung Jang et al, 2016, Pathology - Research and Practice CrossRef
3. The role and potential mechanism of O-Glycosylation in gastrointestinal tumors
   Feinan Zhou et al, 2022, Pharmacological Research CrossRef
4. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling
   Mingzuo Jiang et al, 2016, Oncotarget CrossRef
5. Non-targeted metabolomics reveals diagnostic biomarker in the tongue coating of patients with chronic gastritis
   Xiyan Mu et al, 2019, Journal of Pharmaceutical and Biomedical Analysis CrossRef
6. Increased O-GlcNAcylation promotes IGF-1 receptor/PhosphatidyI Inositol-3 kinase/Akt pathway in cervical cancer cells
   Victoria Jiménez-Castillo et al, 2022, Scientific Reports CrossRef
7. O-GlcNAcylation of the Signaling Scaffold Protein, GNB2L1 Promotes its Degradation and Increases Metastasis of Gastric Tumours
   Shimeng Cheng et al, 2016, Biochemical and Biophysical Research Communications CrossRef
8. ‘O-GlcNAc Code’ Mediated Biological Functions of Downstream Proteins
   Linhong Zhao et al, 2018, Molecules CrossRef
9. Drug resistance related to aberrant glycosylation in colorectal cancer
   Ninon Very et al, 2018, Oncotarget CrossRef
10. Expression and clinical significance of ATM and PUMA gene in patients with colorectal cancer
    Hui Xiong et al, 2017, Oncology Letters CrossRef
11. Interactome analysis of transforming growth factor-β-activated kinase 1 inHelicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37
    Olga Sokolova et al, 2018, Oncotarget CrossRef
12. O-GlcNAcylation in cancer development and immunotherapy
    Xue-Fen He et al, 2023, Cancer Letters CrossRef